![](/img/cover-not-exists.png)
Phase 1 trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in advanced solid tumors
Strauss, Julius, Heery, Christopher, Schlom, Jeffrey, Madan, Ravi A., Cao, Liang, Kang, Zhigang, Lamping, Elizabeth, Marte, Jennifer L, Donahue, Renee N, Grenga, Italia, Cordes, Lisa M, Christensen, OLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-2653
Date:
January, 2018
File:
PDF, 1.82 MB
english, 2018